• OPEN AN ACCOUNT
Indian Indices
Sensex
77,264.51 330.92
( 0.43%)
Global Indices
Nasdaq
53,569.16 -21.28
(-0.04%)
Dow Jones
7,731.77 -20.22
(-0.26%)
Hang Seng
66,369.62 237.64
(0.36%)
Nikkei 225
10,816.31 23.77
(0.22%)
Forex
USD-INR
95.48 0.22
(0.23%)
EUR-INR
111.24 0.16
(0.15%)
GBP-INR
129.74 0.04
(0.03%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Lupin Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500257
INE326A01037
658.9991894
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LUPIN
15.02
99455.32
EPS(TTM)
Face Value()
Div & Yield %
144.81
2
0.83
 

As on: Aug 28, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
2,175.00 10.40 15828 15.02
Stock Price Details
Open Price() 2,160.05
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 2,179.50
Today's Low () 2,153.50
52-Week High () 2530
152-Week Low () 1881.8
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.83
Eps 144.81
Book Value 658.9991894
Market Cap (.Cr) 99,455.32
Face Value 2
Market Lot 1
AGM Date Aug
Book Closure Date
ISIN No. INE326A01037


News
Lupin allots 30,967 equity shares under ESOP
Lupin inks pact with Tenpoint Therapeutics to commercialize YUVEZZI in select countries
Lupin receives USFDA approval for Pitolisant Tablets, 4.45 mg and 17.8 mg
Lupin Ltd slips for fifth straight session
Lupin receives USFDA approval for Sodium Zirconium Cyclosilicate for Oral Suspension
Lupin consolidated net profit rises 16.08% in the June 2026 quarter
Lupin launches Sugammadex Injection in U.S. market
Lupin receives USFDA approval for Diazepam Injection USP
Lupin to table results
Lupin grants exclusive rights to Kaveri Therapeutics Inc. for advancing two oncology programs
More
Corporate Details
Incoporation Year   : 1983
Chairman : M D Gupta
Bussiness Group : Indian Private
Registered Office
Lupin Ltd
Kalpataru Inspire 3rd Floor,
Off Western Exp HW Santacruz-E,
Mumbai,
Maharashtra-400055
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-6640 2323
Fax:91-22-6640 8131
Fax:91-22-66317458
E-Mail : investorservices@lupinpharma.com
URL : https://www.lupin.com/


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 100
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Shariah 50
  • CNX 500
  • Nifty Midcap50
  • CNX Midcap
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi